↓ Skip to main content

Ten Years of Infliximab for Crohn’s Disease

Overview of attention for article published in Inflammatory Bowel Diseases, July 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ten Years of Infliximab for Crohn’s Disease
Published in
Inflammatory Bowel Diseases, July 2013
DOI 10.1097/mib.0b013e318281f4c4
Pubmed ID
Authors

Emma J. Eshuis, Charlotte P. Peters, Adriaan A. van Bodegraven, Joep F. Bartelsman, Willem Bemelman, Paul Fockens, Geert R. A. M. D’Haens, Pieter C. F. Stokkers, Cyriel Y. Ponsioen

Abstract

Aim was to assess the long-term clinical efficacy of infliximab therapy in patients with Crohn's disease treated in a cohort of 2 tertiary referral centers in the Netherlands.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Brazil 1 1%
Unknown 73 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 23%
Other 7 9%
Student > Postgraduate 7 9%
Student > Ph. D. Student 6 8%
Student > Master 6 8%
Other 15 20%
Unknown 17 23%
Readers by discipline Count As %
Medicine and Dentistry 44 59%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Arts and Humanities 2 3%
Computer Science 2 3%
Business, Management and Accounting 1 1%
Other 2 3%
Unknown 20 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2013.
All research outputs
#14,600,553
of 25,374,647 outputs
Outputs from Inflammatory Bowel Diseases
#2,255
of 3,731 outputs
Outputs of similar age
#108,556
of 206,711 outputs
Outputs of similar age from Inflammatory Bowel Diseases
#32
of 52 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,731 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,711 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.